Washington Trust Advisors’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.19K | Hold |
125
| – | – | ﹤0.01% | 622 |
|
|
2025
Q1 | $1.31K | Hold |
125
| – | – | ﹤0.01% | 618 |
|
|
2024
Q4 | $2.95K | Hold |
125
| – | – | ﹤0.01% | 601 |
|
|
2024
Q3 | $4.49K | Hold |
125
| – | – | ﹤0.01% | 589 |
|
|
2024
Q2 | $4.41K | Hold |
125
| – | – | ﹤0.01% | 582 |
|
|
2024
Q1 | $3.55K | Hold |
125
| – | – | ﹤0.01% | 608 |
|
|
2023
Q4 | $1.66K | Hold |
125
| – | – | ﹤0.01% | 648 |
|
|
2023
Q3 | $1.12K | Hold |
125
| – | – | ﹤0.01% | 661 |
|
|
2023
Q2 | $1.41K | Hold |
125
| – | – | ﹤0.01% | 640 |
|
|
2023
Q1 | $1.44K | Hold |
125
| – | – | ﹤0.01% | 747 |
|
|
2022
Q4 | $1.45K | Hold |
125
| – | – | ﹤0.01% | 747 |
|
|
2022
Q3 | $2K | Buy |
+125
| New | +$2K | ﹤0.01% | 848 |
|
|
2022
Q1 | – | Sell |
-63
| Closed | -$1K | – | 1003 |
|
|
2021
Q4 | $1K | Buy |
+63
| New | +$1K | ﹤0.01% | 981 |
|